ScienceDaily: Top Health News |
Posted: 01 Dec 2021 05:39 PM PST A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study. The results suggest that countering the activity of these cells could be a new therapeutic approach for such conditions. |
Researchers develop model for treating HIV/AIDS, depression Posted: 01 Dec 2021 01:20 PM PST |
Eye imaging technology breaks through skin by crossing beams Posted: 01 Dec 2021 01:20 PM PST Biomedical engineers have demonstrated a method for increasing the depth at which optical coherence tomography (OCT) can image structures beneath skin. The new 'dual-axis' approach opens new possibilities for OCT to be used in applications such as spotting skin cancer, assessing burn damage and healing progress, and guiding surgical procedures. |
Posted: 01 Dec 2021 12:01 PM PST |
Compound shows promise for minimizing erratic movements in Parkinson’s patients Posted: 01 Dec 2021 12:01 PM PST |
New way of identifying early risk of cardiovascular disease Posted: 01 Dec 2021 11:53 AM PST The risk of developing cardiovascular disease is strongly associated with 'bad' LDL cholesterol. A large study now shows that two proteins that transport cholesterol particles in the blood provide early and reliable risk information. The researchers now advocate introducing new guidelines for detecting cardiac risk and say the results may pave the way for early treatment, which could help lower morbidity and fatality rates. |
Targeting the brain’s immune cells may help prevent or treat Alzheimer’s disease Posted: 01 Dec 2021 11:53 AM PST A gene mutation linked to Alzheimer's disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study. The team also found that blocking the pathway -- with a drug that's currently being tested in cancer clinical trials -- protects against many features of the condition in a preclinical model. The results could lead to new strategies to block the development of Alzheimer's disease or slow its progression. |
Effectiveness of ointment that kills antibiotic-resistant bacteria shown Posted: 01 Dec 2021 11:53 AM PST |
Research reveals new evidence that sugary beverage tax impacts are sustainable, effective Posted: 01 Dec 2021 11:53 AM PST |
Posted: 01 Dec 2021 10:36 AM PST |
Researchers identify key RNA 'gatekeeper' in gene expression, pointing to possible new drug targets Posted: 01 Dec 2021 09:43 AM PST Researchers have identified the first non-coding RNA that controls formation of chromosome loops, which govern gene expression. Jpx RNA was previously thought to be involved only in X chromosome inactivation, a necessary step in development of female embryos. This discovery could create new targets for drug developers. |
Unorthodox 'exercise in a pill' could offer simple solution for at-risk patients Posted: 01 Dec 2021 08:19 AM PST |
Posted: 01 Dec 2021 08:19 AM PST |
Footprints from site a at Laetoli, Tanzania, are from early humans, not bears Posted: 01 Dec 2021 08:19 AM PST The oldest unequivocal evidence of upright walking in the human lineage are footprints discovered at Laetoli, Tanzania in 1978, by paleontologist Mary Leakey and her team. The bipedal trackways date to 3.7 million years ago. Another set of mysterious footprints was partially excavated at nearby Site A in 1976 but dismissed as possibly being made by a bear. A recent re-excavation of the Site A footprints at Laetoli and a detailed comparative analysis reveal that the footprints were made by an early human -- a bipedal hominin. |
The diabetes medication that could revolutionize heart failure treatment Posted: 01 Dec 2021 05:52 AM PST A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment. Early research had shown that SGLT2 inhibitors could help around half of heart failure patients -- those with a condition known as reduction ejection fraction. But a new study shows that the medication could be beneficial for all heart failure patients -- including those with a second type of heart failure called preserved ejection fraction. |
Study links high cholesterol, cardiovascular disease to plastics Posted: 01 Dec 2021 05:51 AM PST |
Coffee time: Caffeine improves reaction to moving targets Posted: 01 Dec 2021 05:51 AM PST |
Posted: 01 Dec 2021 05:51 AM PST As cannabis is legalized in more areas, it has become increasingly popular as a medicinal and recreational drug. This plant produces a pungent, skunk-like odor that is pleasing to some but repulsive to others. Now, researchers have discovered a new family of prenylated volatile sulfur compounds (VSCs) that give cannabis its characteristic skunky aroma. The findings open up opportunities to investigate the molecules for medicinal benefits, the researchers say. |
MRI reveals altered brain structure in fetuses exposed to alcohol Posted: 01 Dec 2021 05:51 AM PST |
In children with multiple sclerosis, teriflunomide tempers lesion growth Posted: 30 Nov 2021 02:40 PM PST A phase 3 clinical trial tested the safety and efficacy of teriflunomide, an oral immunomodulatory drug, in children with multiple sclerosis. Although the medication did not prevent disease relapses to a greater extent than placebo, the option for some patients to switch from placebo to teriflunomide before the end of the trial likely biased the results against treatment efficacy. The drug appeared to reduce the number of new or enlarged lesions that are detected through MRI. |
Altered DNA repair and DNA damage in neurodegenerative conditions Posted: 30 Nov 2021 02:39 PM PST Researchers have confirmed a link between altered DNA repair and increased DNA damage associated with spinocerebellar ataxia type 7 (SCA7), a debilitating, sometimes deadly neurodegenerative condition causing movement disorders. Their work also revealed a potential therapeutic target for the currently incurable and difficult to treat condition. |
Synthetic tissue can repair hearts, muscles, and vocal cords Posted: 30 Nov 2021 12:04 PM PST |
High-speed holography of cells spots physical beacons of disease Posted: 30 Nov 2021 12:04 PM PST |
Posted: 30 Nov 2021 11:15 AM PST |
Biosensor barcodes identify, detail ‘chatting’ among cancer cells Posted: 30 Nov 2021 10:02 AM PST Ever since the first barcode appeared on a pack of chewing gum in 1974, the now-ubiquitous system has enabled manufacturers, retailers and consumers to quickly and effectively identify, characterize, locate and track products and materials. Scientists now demonstrate how they can do the same thing at the molecular level, studying the ways cancer cells 'talk' with one another. |
Ubiquitous food additive alters human microbiota and intestinal environment Posted: 30 Nov 2021 10:02 AM PST New clinical research indicates that a widely used food additive, carboxymethylcellulose, alters the intestinal environment of healthy persons, perturbing levels of beneficial bacteria and nutrients. These findings demonstrate the need for further study of the long-term impacts of this food additive on health. |
3D printing of blood plasma may speed up wound healing Posted: 30 Nov 2021 08:25 AM PST |
Successful treatment in mice for severe childhood cancer Posted: 30 Nov 2021 08:25 AM PST |
Distortion: Researchers discover new strategy for antibodies to disable viruses Posted: 30 Nov 2021 08:25 AM PST It is widely understood that antibodies neutralize viruses by latching onto their surfaces and blocking them from infecting host cells. But new research reveals that this barrier method isn't the only way that antibodies disable viruses. An international team of researchers has discovered that antibodies also distort viruses, thereby preventing them from properly attaching to and entering cells. |
Scientists can control brain circuits, behavior, and emotion using light Posted: 30 Nov 2021 08:25 AM PST |
Global HIV viral suppression rates too low among children and adolescents Posted: 30 Nov 2021 07:15 AM PST |
Posted: 30 Nov 2021 07:14 AM PST |
Reduced meat diet has many advantages Posted: 30 Nov 2021 07:14 AM PST Which diet is better: moderately reduce meat consumption and eat more fruit, vegetables and wholegrain products or eating more fish and seafood? Or even switch completely to a vegan diet? A new study shows that the answer to these questions is not as clear-cut as one might think -- depending on which impacts one closely looks. |
Breakthrough tool to show how much exoskeletons reduce back injury risk Posted: 30 Nov 2021 07:14 AM PST A study reveals a breakthrough tool to assess the effect of exoskeletons on injury risk. The tool, called Exo-LiFFT, is an interactive calculator that will help companies looking for ways to overcome workforces struggling with musculoskeletal injuries, missed work, and accelerated retirement amongst skilled laborers. |
Nonverbal social interactions – even with unfriendly avatars – boost cooperation Posted: 30 Nov 2021 07:14 AM PST |
Cell types of the iris in mice Posted: 30 Nov 2021 07:14 AM PST |
Correcting inherited gene alterations speeds up Posted: 30 Nov 2021 07:14 AM PST |
Courting success: Why the 'head' outsmarts the body in basketball Posted: 30 Nov 2021 07:14 AM PST |
Potential new treatment for Alzheimer’s disease would be relatively cheap Posted: 30 Nov 2021 07:12 AM PST Researchers have discovered a protein involved in the development of Alzheimer's disease. Studies in mice showed that eliminating this protein entirely or using drugs to block its function reduced physical changes in the brain associated with the disease and improved memory. Drug therapy that aims to block the protein's activity could be a more effective treatment than what is currently available, as well as being cheaper. |
Early interventions could help counteract muscle loss Posted: 30 Nov 2021 05:43 AM PST Weakening muscles are a natural part of the aging process, but for some people with a condition called sarcopenia the decline is abnormally fast. A new study suggests that the early stages of sarcopenia could be counteracted with timely interventions designed to preserve physical and cognitive function and manage chronic conditions. |
Researchers model circadian clock neurons in a day-active animal Posted: 30 Nov 2021 05:42 AM PST It's no secret that jet lag and night-shift work can wreak havoc on the way our body's internal clock syncs up our daily wake-sleep cycle, known as circadian rhythm, but now researchers say they are a step closer to understanding how the brain creates behavioral rhythms optimized for diurnal, rather than nocturnal, life. |
Rates of type 2 diabetes are higher in people with one of various common psychiatric disorders Posted: 29 Nov 2021 06:28 PM PST |
Telehealth-delivered diet and exercise program eased knee pain and triggered weight loss Posted: 29 Nov 2021 02:27 PM PST |
Artificial intelligence that understands object relationships Posted: 29 Nov 2021 12:51 PM PST |
Heart repair and regeneration after a heart attack Posted: 29 Nov 2021 12:51 PM PST Twenty years ago, clinicians first attempted to regenerate a failing human heart by injecting muscle myoblasts into the heart during a bypass operation. Despite high initial hopes and multiple experimental and clinical studies since then, outcomes have been neutral or marginally positive for a wide variety of attempts to remuscularize an injured heart. Yet hope remains that current and future strategies will yield clinical regenerative heart therapies, experts explain. |
De-cluttering may not help people with dementia Posted: 29 Nov 2021 12:50 PM PST A clutter-free environment may not help people with dementia carry out daily tasks -- according to a new study. Researchers studied whether people with dementia were better able to carry out tasks, such as making a cup of tea, at home - surrounded by their usual clutter - or in a clutter-free environment. They were surprised to find that participants with moderate dementia performed better when surrounded by their usual clutter. |
Which side is which? How the brain perceives borders Posted: 29 Nov 2021 12:50 PM PST |
Which glioblastoma patients will respond to immunotherapy? Posted: 29 Nov 2021 12:50 PM PST Scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas -- the most common and malignant of primary brain tumors -- might benefit from immunotherapy. The treatment could extend survival for an estimated 20% to 30% of patients. Currently, patients with glioblastoma do not receive this life-prolonging treatment because it has not been fully understood which of them could benefit. |
Posted: 29 Nov 2021 12:50 PM PST |
'Transformational' approach to machine learning could accelerate search for new disease treatments Posted: 29 Nov 2021 12:50 PM PST |
How obesity damages the skeletal muscle metabolism Posted: 29 Nov 2021 09:28 AM PST A decline in metabolism and endurance of skeletal muscle is commonly observed in obese patients, but the underlying mechanism is not well-understood. A research team uncovers a new mechanism to explain how obesity jeopardizes the functions of skeletal muscle and provides a potential treatment against the disease. |
Parallels in human, dog oral tumors could speed new therapies Posted: 29 Nov 2021 09:28 AM PST |
Potential new therapeutic pathway to clear chronic viral infections Posted: 29 Nov 2021 09:28 AM PST |
Getting the most therapeutic potential out of cells Posted: 29 Nov 2021 09:27 AM PST |
Farmers spread Transeurasian languages Posted: 29 Nov 2021 09:27 AM PST |
A tough attachment between rotator cuff, bone achieved through unique fibrous architecture Posted: 29 Nov 2021 07:57 AM PST |
Scientists discover potential cause of Alzheimer’s Disease Posted: 29 Nov 2021 07:56 AM PST |
Study reveals a protein’s key contribution to heterogeneity of neurons Posted: 29 Nov 2021 07:56 AM PST |
Method to reveal undesired biological effects of chemicals Posted: 29 Nov 2021 07:56 AM PST |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |